Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Mark De Souza - aVenture Research

Mark De Souza

AddedMar 31, 2024

UpdatedOct 12, 2026

Mark De Souza

Mark De Souza

CEO, Sonalasense

Mark De Souza's Career

Rnaderm Therapeutics

Seed$750k

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Mark De Souza's Investments

1 investments since 2019

1 operating

Investments view

Group by

2019

1

DermBiont
Series A · June 2019$8M
Series A · June 2019

Berkeley, CA, US

Founder

Willow Neuroscience

Seed$25.2kEmeryville, CA, US

Founder

Phoenicis

Public$4.3MHingham, MA, US

Board Member· Board

Co-Founder

FibRx Derm

Seed$1.8MBerkeley, CA, US

Co-Founder

Wings Therapeutics

Seed$1.5MBerkeley, CA, US

Founder

Myotherix

Pre-Seed$1MUnion City, CA, US

Co-Founder

Flightpath Biosciences

Series A$1.1MBerkeley, CA, US

Board Member· Board

Co-Founder

Sonalasense

Series B$21.1MBerkeley, CA, US

CEO· C-Suite · Management

Lotus Tissue Repair

Series A$26MCambridge, MA, US

Board Member· Board

Co-Founder & CEO· C-Suite · Management

Co-Founder

People Similar to Mark De Souza

Dan BradburyFounder · Biobrit

Wendye RobbinsCo-Founder · NeurogesX

Marc PennFounder · SironRX Therapeutics

Paulina HillBoard Member · Lyra Therapeutics

Richard NeubigCo-Founder · FibrosIX

Chris EhrlichBoard Member · Satori Pharmaceuticals

Similar to Rnaderm Therapeutics

Aldena TherapeuticsBoston, MA, USTreatmentsest. 2022Aldena TherapeuticsBoston, MA, US · est. 2022

Aldena Therapeutics: A biotech startup innovating siRNA-based treatments for skin conditions.

Series A · $30M5

NovaDerm AidDallas, TX, USBiotech, Softwareest. 2022NovaDerm AidDallas, TX, US · est. 2022

Dallas-based software & biotech company founded in 2022.

Seed · $675k50

AirnaStanford, CA, USRNA Therapiesest. 2021AirnaStanford, CA, US · est. 2021

Stanford-based AIRNA pioneers RNA editing therapies for rare and common health ailments.

Series B · $245M30

DermBiontBoston, MA, USTherapeuticsest. 2017DermBiontBoston, MA, US · est. 2017

DermBiont: A leading precision dermatology firm, developing targeted therapeutics for skin health.

Series B · $108.5M47

Leadership at FibRx Derm

Erkki RuoslahtiCo-Founder

James FordyceCo-Founder

Similar to FibRx Derm

ElucidermSan Diego, CA, USWound Healingest. 2018ElucidermSan Diego, CA, US · est. 2018

Eluciderm, a San Diego-based medical firm, innovates scarless wound healing products since 2018.

SironRX TherapeuticsCleveland, OH, USRegenerative Therapiesest. 2010SironRX TherapeuticsCleveland, OH, US · est. 2010

SironRX Therapeutics: Innovating regenerative therapies for wound repair and scar prevention in the US.

Series A · $3.9M6

Rnaderm TherapeuticsBerkeley, CA, USBiotechest. 2018Rnaderm TherapeuticsBerkeley, CA, US · est. 2018

Berkeley-based biotech company, RNADerm Therapeutics.

Mistral TherapeuticsSan Diego, CA, USFibrosis Treatmentsest. 2011Mistral TherapeuticsSan Diego, CA, US · est. 2011

Mistral Therapeutics: A San Diego-based biotech firm specializing in innovative fibrosis treatments.

Series B · $36.4M6

Similar to Wings Therapeutics

WoundForceFramingham, MA, USTherapeutics, Wound Careest. 2015WoundForceFramingham, MA, US · est. 2015

WoundForce: A specialty therapeutics firm innovating patented solutions for chronic wounds.

Aegle TherapeuticsWoburn, MA, USTherapeutics, Treatmentest. 2013Aegle TherapeuticsWoburn, MA, US · est. 2013

Aegle Therapeutics: A leading biotech firm specializing in treating rare skin disorders using stem cells.

Public · $13.5M10

CarthroniXLos Angeles, CA, USPharmaceuticals, Therapeuticsest. 2015CarthroniXLos Angeles, CA, US · est. 2015

CarthroniX: A pharmaceutical company providing innovative therapy and skin regeneration solutions.

Blade TherapeuticsSouth San Francisco, CA, USDrug Developmentest. 2013Blade TherapeuticsSouth San Francisco, CA, US · est. 2013

Blade Therapeutics: A US-based biopharmaceutical company specializing in fibrosis treatment and drug development.

Series B · $51.5M28

Similar to Willow Neuroscience

Marlinspike TherapeuticsCambridge, MA, USBiotechest. 2021Marlinspike TherapeuticsCambridge, MA, US · est. 2021

Marlinspike Therapeutics: A stealth-mode biotech firm, founded in 2021, based in Cambridge, MA.

Series A · $3.5M7

Nerio TherapeuticsLos Angeles, CA, USBiotechest. 2019Nerio TherapeuticsLos Angeles, CA, US · est. 2019

Los Angeles-based biotech company specializing in life sciences. Founded in 2019.

Series A · $6.5M6

WillowMountain View, CA, USWearable Pumpsest. 2014WillowMountain View, CA, US · est. 2014

Mountain View-based Willow manufactures innovative in-bra wearable breast pumps for women.

Series D · $144.3M127

Westwood Life SciencesChicago, IL, USPharmaceuticalsest. 2013Westwood Life SciencesChicago, IL, US · est. 2013

Westwood Life Sciences: Stealth pharmaceutical provider.

Seed · $1.8M30

Leadership at Phoenicis

Deborah RamsdellCo-Founder

Similar to Phoenicis

Citrine MedicineCambridge, MA, USTherapeutics, Therapiesest. 2019Citrine MedicineCambridge, MA, US · est. 2019

Citrine Medicine: Innovating therapies for rare diseases in China, enhancing patient lives.

Series A · $80M30

Phanes TherapeuticsSan Diego, CA, USDrug Discoveryest. 2016Phanes TherapeuticsSan Diego, CA, US · est. 2016

Phanes Therapeutics: Innovating in immuno-oncology and eye disease drug discovery and development.

Series B · $40M24

Orphan Star TherapeuticsNew York City, NY, USTherapiesest. 2017Orphan Star TherapeuticsNew York City, NY, US · est. 2017

Orphan Star Therapeutics: A NY-based biopharmaceutical firm developing therapies for rare diseases.

Series B · $20M5

Pono PharmaHonolulu, HI, USPharmaceuticalsest. 2012Pono PharmaHonolulu, HI, US · est. 2012

Pono Pharma: Excelling in developing novel therapies for diseases and actively serving communities.

Seed · $1.5M30

Leadership at Myotherix

John KincaidCo-Founder

Michael G. KellyCo-Founder

Similar to Myotherix

Myosana TherapeuticsSeattle, WA, USGene Therapyest. 2018Myosana TherapeuticsSeattle, WA, US · est. 2018

Myosana Therapeutics: A biotech firm innovating non-viral gene delivery to target muscle cells.

StrykagenReno, NV, USDiagnostics, TherapeuticsStrykagenReno, NV, US

Strykagen: Innovating diagnostic and therapeutic tools for rare muscle diseases.

Mahzi TherapeuticsSan Mateo, CA, USBiotechest. 2020Mahzi TherapeuticsSan Mateo, CA, US · est. 2020

Mahzi Therapeutics: A California-based healthcare and biotech firm, founded in 2020.

Series A · $47.3M13

DMD TherapeuticsTherapeuticsest. 2016DMD Therapeuticsest. 2016

Developing proprietary therapeutics for Duchenne muscular dystrophy.

Leadership at Flightpath Biosciences

Curtis ScribnerCo-Founder

Matthew TindallCo-Founder

Similar to Flightpath Biosciences

X-Biotix TherapeuticsWaltham, MA, USAntibioticsest. 2016X-Biotix TherapeuticsWaltham, MA, US · est. 2016

X-Biotix Therapeutics: A biotech firm innovating antibiotic solutions for multi-drug-resistant pathogens.

Series A · $7M9

Taxis PharmaceuticalsMonmouth Junction, NJ, USPharmaceuticalsest. 2009Taxis PharmaceuticalsMonmouth Junction, NJ, US · est. 2009

TAXIS Pharmaceuticals Inc., a biopharmaceutical firm specializing in developing drugs for resistant bacterial pathogens.

Seed · $6.2M28

ArrePathPrinceton, FL, USAnti-Infective Drugsest. 2022ArrePathPrinceton, FL, US · est. 2022

ArrePath: A biotech leader in discovering innovative anti-infective drugs using AI and imaging technologies.

Spectrum AntimicrobialsPetaluma, CA, USInfection Controlest. 2016Spectrum AntimicrobialsPetaluma, CA, US · est. 2016

Spectrum Antimicrobials: Innovating non-antibiotic solutions for diverse infection control.

Series A · $25.9M30

Leadership at Sonalasense

Stuart MarcusFounder

Similar to Sonalasense

Alpheus MedicalOakdale, MN, USMedical Devicesest. 2021Alpheus MedicalOakdale, MN, US · est. 2021

Alpheus Medical: Innovating sonodynamic therapy for solid body cancers.

Series A · $30M5

Sonify BiosciencesBaltimore, MD, USMedical Devicesest. 2012Sonify BiosciencesBaltimore, MD, US · est. 2012

Sonify Biosciences, a Maryland-based medical firm, pioneers in non-chemical ultrasound melanoma treatments.

Neurosonics MedicalBaltimore, MD, USMedical Devicesest. 2018Neurosonics MedicalBaltimore, MD, US · est. 2018

Neurosonics Medical: Pioneering brain tumor ablation with specialized ultrasound devices since 2018.

SonovalBaltimore, MD, USCancer Therapiesest. 2018SonovalBaltimore, MD, US · est. 2018

Sonoval: Pioneering anti-cancer biologic therapies for T-cell lymphomas and solid tumors.

Leadership at Lotus Tissue Repair

Mei-Ru ChenCo-Founder

David WoodleyCo-Founder

James W Fordyce "Jim"Board Member

Similar to Lotus Tissue Repair

WoundForceFramingham, MA, USTherapeutics, Wound Careest. 2015WoundForceFramingham, MA, US · est. 2015

WoundForce: A specialty therapeutics firm innovating patented solutions for chronic wounds.

RenovoDermColumbus, OH, USWound Careest. 2016RenovoDermColumbus, OH, US · est. 2016

RenovoDerm: Ohio-based medical firm specializing in advanced wound care products since 2016.

Biowound SolutionsLas Vegas, NV, USWound Treatmentsest. 2023Biowound SolutionsLas Vegas, NV, US · est. 2023

Las Vegas-based Biowound Solutions develops and offers treatments for chronic wounds.

Seed · $3.6M50

ElucidermSan Diego, CA, USWound Healingest. 2018ElucidermSan Diego, CA, US · est. 2018

Eluciderm, a San Diego-based medical firm, innovates scarless wound healing products since 2018.